Related Experiment Video
Updated: Sep 18, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
Published on: January 30, 2020
[Intravenous ketamine in suicidal crisis : indications and patient referral]
Rayan Nasserdine1, Laura Xhymshiti2, Anne-Charlotte Paporé3
1Psychiatres, Unité humeur et anxiété, Service de spécialités psychiatriques, Département de psychiatrie, Hôpitaux universitaires de Genève, 1211 Genève 14.
Abstract:
Intravenous (IV) ketamine is a rapidly acting therapeutic option for the management of treatment-resistant depression and acute suicidal crisis. Unlike conventional antidepressants, its effects may occur within hours, allowing a rapid reduction in suicidal ideation and psychological distress. Its use remains specialized and requires hospital-based care with medical monitoring and a comprehensive psychiatric assessment. This article provides a practical overview for primary care physicians, focusing on the indications, referral criteria, and role of IV ketamine within the care pathway of patients with treatment-resistant depression or acute suicidal crisis, illustrated by a clinical vignette.
Related Concept Videos
Parenteral Anesthetics: Overview
Cardiopulmonary Resuscitation IV: Pharmacological Management
Psychosis: Goals of Pharmacotherapy
Electroconvulsive Therapy
Pharmaceutical Poisoning: Treatment Strategies
Drug Delivery: Enteral Route
Drugs in...